Laser interstitial thermal therapy in gliomas

Area of Science:

• Neurosurgery
• Oncology
• Medical Technology

Background:

• Laser interstitial thermal therapy (LITT) is an established minimally invasive technique for various brain conditions, including tumors, epilepsy, and necrosis.
• Recent technological advancements, particularly in magnetic resonance (MR) thermography and ablation precision, have enhanced LITT's efficacy and safety.
• The increasing acceptance of LITT in neurosurgical centers is driven by improved outcomes and the availability of commercial laser systems.

Purpose of the Study:

• To review the historical development and evolution of LITT, with a specific focus on its application in treating brain gliomas.
• To explore emerging treatment concepts and ongoing research, such as adjuvant therapies and immunotherapy in conjunction with LITT for glioma management.
• To provide a future outlook on the potential advancements and expanded roles of LITT in neuro-oncology.

Main Methods:

• Literature review of LITT applications in neurosurgery, focusing on glioma treatment.
• Analysis of technological advancements influencing LITT procedures, including MR thermography and ablation systems.
• Examination of recent research on novel therapeutic combinations involving LITT, chemotherapy, radiation, and immunotherapy.

Main Results:

• LITT has a long-standing history as a minimally invasive treatment for brain conditions.
• Improvements in MR thermography and precision have led to wider acceptance of LITT in neurosurgical centers.
• New therapeutic strategies, including adjuvant treatments and immunotherapy, are being explored for enhanced glioma treatment outcomes.

Conclusions:

• LITT is a continuously evolving minimally invasive treatment modality with growing applications in neurosurgery, particularly for brain gliomas.
• Technological progress and innovative combination therapies suggest a promising future for LITT in improving patient outcomes.
• Further research into adjuvant and combined treatment approaches will likely expand the role of LITT in comprehensive brain tumor management.